These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 26342921)

  • 41. Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections.
    Schuetz P; Müller B; Christ-Crain M; Stolz D; Tamm M; Bouadma L; Luyt CE; Wolff M; Chastre J; Tubach F; Kristoffersen KB; Burkhardt O; Welte T; Schroeder S; Nobre V; Wei L; Bhatnagar N; Bucher HC; Briel M
    Evid Based Child Health; 2013 Jul; 8(4):1297-371. PubMed ID: 23877944
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Procalcitonin-guided antibiotic therapy in patients with fever in a general emergency department population: a multicentre non-inferiority randomized clinical trial (HiTEMP study).
    van der Does Y; Limper M; Jie KE; Schuit SCE; Jansen H; Pernot N; van Rosmalen J; Poley MJ; Ramakers C; Patka P; van Gorp ECM; Rood PPM
    Clin Microbiol Infect; 2018 Dec; 24(12):1282-1289. PubMed ID: 29870855
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Adhering to the procalcitonin algorithm allows antibiotic therapy to be shortened in patients with ventilator-associated pneumonia.
    Beye F; Vigneron C; Dargent A; Prin S; Andreu P; Large A; Quenot JP; Bador J; Bruyere R; Charles PE
    J Crit Care; 2019 Oct; 53():125-131. PubMed ID: 31228763
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Optimal use of procalcitonin to rule out bacteremia in patients with possible viral infections.
    Azijli K; Minderhoud TC; de Gans CJ; Lieveld AWE; Nanayakkara PWB
    J Am Coll Emerg Physicians Open; 2022 Jun; 3(3):e12621. PubMed ID: 35601651
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Impact of Procalcitonin Guidance on Management of Adults Hospitalized with Chronic Obstructive Pulmonary Disease Exacerbations.
    Bremmer DN; DiSilvio BE; Hammer C; Beg M; Vishwanathan S; Speredelozzi D; Moffa MA; Hu K; Abdulmassih R; Makadia JT; Sandhu R; Naddour M; Chan-Tompkins NH; Trienski TL; Watson C; Obringer TJ; Kuzyck J; Walsh TL
    J Gen Intern Med; 2018 May; 33(5):692-697. PubMed ID: 29404940
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Procalcitonin-guided diagnosis and antibiotic stewardship revisited.
    Sager R; Kutz A; Mueller B; Schuetz P
    BMC Med; 2017 Jan; 15(1):15. PubMed ID: 28114931
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clinical implications of rapid ePlex® Respiratory Pathogen Panel testing compared to laboratory-developed real-time PCR.
    van Rijn AL; Nijhuis RHT; Bekker V; Groeneveld GH; Wessels E; Feltkamp MCW; Claas ECJ
    Eur J Clin Microbiol Infect Dis; 2018 Mar; 37(3):571-577. PubMed ID: 29222697
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Procalcitonin Testing With Secondary Coinfection in Patients With COVID-19.
    Nadeem R; Aljaghber HM; Elgohary D; Rafeeq A; Aijazi I; Khan HA; Khan MR; Velappan B; Aljanahi MH; Mohamed Ali Elzeiny MG
    Cureus; 2022 Sep; 14(9):e28898. PubMed ID: 36237753
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Efficacy and safety of procalcitonin guidance in reducing the duration of antibiotic treatment in critically ill patients: a randomised, controlled, open-label trial.
    de Jong E; van Oers JA; Beishuizen A; Vos P; Vermeijden WJ; Haas LE; Loef BG; Dormans T; van Melsen GC; Kluiters YC; Kemperman H; van den Elsen MJ; Schouten JA; Streefkerk JO; Krabbe HG; Kieft H; Kluge GH; van Dam VC; van Pelt J; Bormans L; Otten MB; Reidinga AC; Endeman H; Twisk JW; van de Garde EMW; de Smet AMGA; Kesecioglu J; Girbes AR; Nijsten MW; de Lange DW
    Lancet Infect Dis; 2016 Jul; 16(7):819-827. PubMed ID: 26947523
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Role of procalcitonin use in the management of sepsis.
    Gregoriano C; Heilmann E; Molitor A; Schuetz P
    J Thorac Dis; 2020 Feb; 12(Suppl 1):S5-S15. PubMed ID: 32148921
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The cost impact of PCT-guided antibiotic stewardship versus usual care for hospitalised patients with suspected sepsis or lower respiratory tract infections in the US: A health economic model analysis.
    Mewes JC; Pulia MS; Mansour MK; Broyles MR; Nguyen HB; Steuten LM
    PLoS One; 2019; 14(4):e0214222. PubMed ID: 31013271
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Using procalcitonin-guided algorithms to improve antimicrobial therapy in ICU patients with respiratory infections and sepsis.
    Schuetz P; Raad I; Amin DN
    Curr Opin Crit Care; 2013 Oct; 19(5):453-60. PubMed ID: 23817026
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Procalcitonin-guided antibiotic discontinuation in ventilator-associated pneumonia: a prospective observational study.
    Wang Q; Hou D; Wang J; An K; Han C; Wang C
    Infect Drug Resist; 2019; 12():815-824. PubMed ID: 31114263
    [No Abstract]   [Full Text] [Related]  

  • 54. Implementation of Procalcitonin in Antibiotic Stewardship: Derivation of a Consensus Algorithm for Procalcitonin Use in Clinical Practice.
    Park DW; Choi JY; Kim CJ; Kim JH; Kim HB; Lee DG
    Infect Chemother; 2022 Dec; 54(4):621-636. PubMed ID: 36596678
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Guidance of antibiotic therapy with procalcitonin in lower respiratory tract infections: insights into the ProHOSP study.
    Schuetz P; Christ-Crain M; Albrich W; Zimmerli W; Mueller B;
    Virulence; 2010; 1(2):88-92. PubMed ID: 21178422
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The Role of Procalcitonin as an Antimicrobial Stewardship Tool in Patients Hospitalized with Seasonal Influenza.
    Christensen I; Berild D; Bjørnholt JV; Jelsness-Jørgensen LP; Debes SM; Haug JB
    Antibiotics (Basel); 2023 Mar; 12(3):. PubMed ID: 36978440
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Procalcitonin-based therapeutic strategy to reduce antibiotic use in patients after cardiac surgery: a randomized controlled trial.
    Maravić-Stojković V; Lausević-Vuk L; Jović M; Ranković A; Borzanović M; Marinković J
    Srp Arh Celok Lek; 2011; 139(11-12):736-42. PubMed ID: 22338468
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Procalcitonin-guided antibiotic use vs a standard approach for acute respiratory tract infections in primary care.
    Briel M; Schuetz P; Mueller B; Young J; Schild U; Nusbaumer C; Périat P; Bucher HC; Christ-Crain M
    Arch Intern Med; 2008 Oct; 168(18):2000-7; discussion 2007-8. PubMed ID: 18852401
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A retrospective propensity-score-matched cohort study of the impact of procalcitonin testing on antibiotic use in hospitalized patients during the first wave of COVID-19.
    Sandoe JAT; Grozeva D; Albur M; Bond SE; Brookes-Howell L; Dark P; Euden J; Hamilton R; Hellyer TP; Henley J; Hopkins S; Howard P; Howdon D; Knox-Macaulay C; Llewelyn MJ; Maboshe W; McCullagh IJ; Ogden M; Parsons HK; Partridge DG; Powell N; Prestwich G; Shaw D; Shinkins B; Szakmany T; Thomas-Jones E; Todd S; West RM; Carrol ED; Pallmann P
    J Antimicrob Chemother; 2024 Nov; 79(11):2792-2800. PubMed ID: 39248146
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The role of lung ultrasound in procalcitonin-guided antibiotic discontinuation in ventilator-associated pneumonia.
    Ammar MA; Hilal A; Abdalla W
    Indian J Anaesth; 2022 Jun; 66(6):431-435. PubMed ID: 35903590
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.